26825-95-6

Basic information

• Product Name: methyl 12-bromododecanoate
• Synonyms: methyl 12-bromododecanoate;12-bromo-dodecanoic acid methyl ester
• CAS NO: 26825-95-6
• Molecular Formula: C₁₃H₂₅BrO₂
• Molecular Weight: 293.25
• Mol File: 26825-95-6.mol
• Article Data: 14

Chemical Properties

• Appearance: /
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• CAS DataBase Reference: methyl 12-bromododecanoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 12-bromododecanoate(26825-95-6)
• EPA Substance Registry System: methyl 12-bromododecanoate(26825-95-6)

Safety Data

• Hazardous Substances Data: 26825-95-6(Hazardous Substances Data)

Usage

General Description

Methyl 12-bromododecanoate is a chemical compound with the molecular formula C13H25BrO2. It is a type of methyl ester, which is a derivative of dodecanoic acid, also known as lauric acid. The presence of the bromine atom in the 12th position of the dodecanoate chain gives this compound specific chemical properties and reactivity. Methyl 12-bromododecanoate is primarily used in organic synthesis, particularly in the production of various types of esters and other organic compounds. The compound may also be used as an intermediate in the pharmaceutical and fragrance industries, and in research and development of new chemical compounds. Additionally, it can be used as a building block in the synthesis of surfactants and other specialty chemicals.

Upstream product

• 67-56-1 methanol 
• 505-95-3 12-hydroxydodecanoic acid 
• 73367-80-3 12-bromododecanoic acid 
• 558-13-4 carbon tetrabromide 
• 71655-36-2 methyl 12-hydroxydodecanoate 
• 76999-24-1 diethyl (10-bromodecyl)malonate 
• 947-05-7 oxacyclotridecan-2-one 
• 5675-51-4 1,12-dodecandiol 
• 87521-75-3 methyl 12-p-toluenesulfonyloxydodecanoate 
• 186581-53-3 diazomethane 

Downstream Products

• 160256-29-1 12-Bromo-2-phenylselanyl-dodecanoic acid methyl ester 
• 108545-36-4 12-(2-Nitro-phenylselanyl)-dodecanoic acid methyl ester 
• 121942-45-8 13-Benzenesulfonyl-15-(tert-butyl-dimethyl-silanyloxy)-pentadecanoic acid methyl ester 
• 1027059-42-2 12-Benzhydryloxy-dodecanoic acid methyl ester 
• 151309-57-8 methyl 12-phenoxydodecanoate 
• 426210-64-2 12-(16-benzyl-1,4,10,13-tetraoxa-7,16-diaza-cyclooctadec-7-yl)-dodecanoic acid methyl ester 
• 753498-16-7 methyl 12-(3,5-di-tert-butylphenoxy)dodecanoate 
• 944395-53-3 C₆H₃OHC₅H₁₁O(CH₂)7CO₂CH₂(CH₂)4H 
• 944395-55-5 C₆H₃OHC₆H₁₃(CH₂)7CO₂CH₂O(CH₂)4H 
• 944395-57-7 C₆H₃OHC₆H₁₃(CH₂)7CO₂CH₂O(CH₂)4H 
• 503310-23-4 12-(3,5-di-tert-butylphenoxy)dodecanoic acid 
• 753498-18-9 12-(3,5-di-tert-butyl-phenoxy)-dodecanoic acid 3-(tert-butyl-dimethyl-silanyloxy)-2-(2-diphenylacetylamino-acetylamino)-propyl ester 
• 426210-66-4 12-(16-benzyl-1,4,10,13-tetraoxa-7,16-diaza-cyclooctadec-7-yl)-dodecanoic acid 
• 328934-28-7 12-(16-benzyl-1,4,10,13-tetraoxa-7,16-diaza-cyclooctadec-7-yl)-1-{16-[12-(16-benzyl-1,4,10,13-tetraoxa-7,16-diaza-cyclooctadec-7-yl)-dodecanoyl]-1,4,10,13-tetraoxa-7,16-diaza-cyclooctadec-7-yl}-dodecan-1-one 

Relevant articles and documents

COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF AGENTS

The disclosure features amino lipids and compositions involving the same. Nanoparticle compositions include an amino lipid as well as additional lipids such as phospholipids, structural lipids, PEG lipids, or a combination thereof. Nanoparticle compositions further including therapeutic and/or prophylactic agents such as RNA are useful in the delivery of therapeutic and/or prophylactic agents to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.

COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Nanoparticle compositions further including therapeutic and/or prophylactics such as RNA are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.

Evaluation of coumarin-based fluorogenic P450 BM3 substrates and prospects for competitive inhibition screenings

Fluorescence-based assays for the cytochrome P450 BM3 monooxygenase from Bacillus megaterium address an attractive biotechnological challenge by facilitating enzyme engineering and the identification of potential substrates of this highly promising biocatalyst. In the current study, we used the scarcity of corresponding screening systems as an opportunity to evaluate a novel and continuous high-throughput assay for this unique enzyme. A set of nine catalytically diverse P450 BM3 variants was constructed and tested toward the native substrate-inspired fluorogenic substrate 12-(4-trifluoromethylcoumarin-7- yloxy)dodecanoic acid. Particularly high enzyme-mediated O-dealkylation yielding the fluorescent product 7-hydroxy-4-trifluoromethylcoumarin was observed with mutants containing the F87V substitution, with A74G/F87V showing the highest catalytic efficiency (0.458 min-1 μM-1). To simplify the assay procedure and show its versatility, different modes of application were successfully demonstrated, including (i) the direct use of NADPH or its oxidized form NADP+ along with diverse NADPH recycling systems for electron supply, (ii) the use of cell-free lysates and whole-cell preparations as the biocatalyst source, and (iii) its use for competitive inhibition screens to identify or characterize substrates and inhibitors. A detailed comparison with known, fluorescence-based P450 BM3 assays finally emphasizes the relevance of our contribution to the ongoing research.